EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Screening of Early SARS-CoV-2 Variants of Concern by Pyrosequencing

Susanne C Duwe, Ashkan Ghassemi iD, Sofia Paraskevopoulou iD, Jeanette Milde, Thorsten Wolff iD, Max von Kleist iD, Ralf Dürrwald iD, Martin Hölzer, Djin-Ye Oh

International Journal of Molecular Sciences · 30.10.2026 · 27 (21) · 9769

DOI: 10.3390/ijms27219769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2026. Verfasst von Susanne C Duwe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit 17: Influenza and Other Respiratory Viruses, Robert Koch Institute, 13353 Berlin, Germany. Hauptthemen laut MEDLINE: SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Ministry of Health, Federal Ministry of Research, Technology and Space, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 variants of concern (VOCs) emerged in late 2020 and were characterized by increased transmissibility, virulence, or antigenic drift. Rapid identification in diagnostic materials is essential for effective implementation of public health responses. The spike gene, essential in viral entry and immune escape, frequently harbors VOC-specific mutations. Their detection by conventional sequencing methods remains time-consuming. A nested RT-PCR-based pyrosequencing (PSQ) assay was designed targeting three mutation-dense regions of the SARS-CoV-2 spike gene. Analytical specificity was assessed using defined controls. Clinical validation involved 175 SARS-CoV-2-positive specimens from the national German acute respiratory infections (ARI) sentinel covering Alpha, Beta, and Delta variants, with different subsets of spike mutations analyzed by PSQ. PSQ generated interpretable pyrograms and enabled reliable detection of predefined VOC-associated spike mutations. Direct comparison of PSQ calls with the corresponding WGS-derived sequences showed 98.6% concordance (489/496 evaluable comparisons). The workflow enabled same-day mutation profiling directly from diagnostic material, providing rapid sequence-level information on mutations associated with increased transmissibility and immune escape. These findings demonstrate that PSQ provides rapid and reliable screening of predefined spike mutations associated with early SARS-CoV-2 VOCs. The workflow may complement whole-genome sequencing in surveillance settings where rapid mutation-level information is required. In a broader sense, the study demonstrates a data-driven approach for developing and periodically adapting targeted molecular surveillance assays as viral populations evolve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19HumansMutationHigh-Throughput Nucleotide SequencingSensitivity and Specificity

Stichwörter der Autor:innen

COVID-19 surveillanceSARS-CoV-2SARS-CoV-2 VOC screeninggenome surveillancemolecular diagnosticspyrosequencingrapid identificationspike genevariants of concernvirus mutations

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Unit 17: Influenza and Other Respiratory Viruses, Robert Koch Institute, 13353 Berlin, Germany.
  • Genome Competence Center (MF1), Robert Koch Institute, 13353 Berlin, Germany.
  • Molecular Epidemiology, Berlin Institute of Health, Charité Universitätsmedizin Berlin, 10178 Berlin, Germany.
  • Project Group 5 (P5): Systems Medicine of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
  • Department of Mathematics and Computer Science, Freie Universität Berlin, 14195 Berlin, Germany.

ORCID-Profile: Ashkan Ghassemi, Sofia Paraskevopoulou, Thorsten Wolff, Max von Kleist, Ralf Dürrwald

Förderung

  • Federal Ministry of Health
  • Federal Ministry of Research, Technology and Space
  • European Commission
  • German Ministry of Health

Zitieren

APA

Duwe, S. C., Ghassemi, A., Paraskevopoulou, S., Milde, J., Wolff, T., von Kleist, M., Dürrwald, R., Hölzer, M., & Oh, D. Y. (2026). Rapid Screening of Early SARS-CoV-2 Variants of Concern by Pyrosequencing. International Journal of Molecular Sciences, 27(21), 9769. https://doi.org/10.3390/ijms27219769

Vancouver

Duwe SC, Ghassemi A, Paraskevopoulou S, Milde J, Wolff T, von Kleist M, et al. Rapid Screening of Early SARS-CoV-2 Variants of Concern by Pyrosequencing. International Journal of Molecular Sciences. 2026;27(21):9769. doi:10.3390/ijms27219769

BibTeX
@article{Duwe2026,
  author = {Duwe, Susanne C and Ghassemi, Ashkan and Paraskevopoulou, Sofia and Milde, Jeanette and Wolff, Thorsten and von Kleist, Max and Dürrwald, Ralf and Hölzer, Martin and Oh, Djin-Ye},
  title = {Rapid Screening of Early SARS-CoV-2 Variants of Concern by Pyrosequencing},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9769},
  doi = {10.3390/ijms27219769}
}
Kostenlos starten →